Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2011-02-15
2011-02-15
Landsman, Robert (Department: 1646)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S350000, C530S399000
Reexamination Certificate
active
07888312
ABSTRACT:
The invention provides a composition for treatment of a localized bacterial infection and bacterial related disease comprising at least one CSF or fragment or derivative thereof. Also provided is the use of at least one colony stimulating factor (CSF) or fragment or derivative thereof having essentially the biological functionality and activity of the CSF for preparing a medicament for the treatment of a localized bacterial infection and bacterial related disease. The CSF is selected from granulocyte colony-stimulating factor (G-CSF), macrophage colony-stimulating factor (M-CSF), granulocyte-macrophage colony-stimulating factor (GM-CSF), and multi-colony stimulating factor. A method of treatment of a mammal suffering from a localized bacterial infection and bacterial related disease is provided. The localized bacterial infection and bacterial related disease may be a periodontal disease or sinusitis.
REFERENCES:
patent: 4804530 (1989-02-01), Sampathkumar
patent: 4810643 (1989-03-01), Souza
patent: 5023082 (1991-06-01), Friedman et al.
patent: 5162111 (1992-11-01), Grabstein et al.
patent: 5976523 (1999-11-01), Awaya et al.
patent: 6660258 (2003-12-01), Tovey
patent: 6682718 (2004-01-01), O'Uchi et al.
patent: 6689351 (2004-02-01), Pierce et al.
patent: 2005/0008614 (2005-01-01), Nieland et al.
patent: 2007/0105824 (2007-05-01), Erickson-Miller et al.
Soskolne W. A., Crit. Rev. Oral Biol. Med. 8: 164-174, 1997.
B. Weston, et al. “Severe Congenital Neutropenia: Clinical Effects and Neutrophil Function During Treatment with Granulocyte Colony-Stimulating Factor”Journal of Laboratory and Clinical Medicinevol. 117, No. 4 (1991) pp. 282-290.
J. Gamonal, et al. “Delayed Neutrophil Apoptosis in Chronic Periodontitis Patients”Journal of Clinical Periodontologyvol. 30 (2003) pp. 616-623.
J. Goultschin, et al. “The Relationship Between Peripheral Levels of Leukocytes and Neutrophils and Periodontal Disease Status in a Patient with Congenital Neutropenia”Periodontal Disease in Congenital Neutropeniavol. 71, No. 9 (2000) pp. 1499-1505.
M.K. Seow, et al. “Cohen Syndrome with Neutropenia-Induced Periodontitis Managed with Granulocyte Colony-Stimulating Factor (G-CSF): Case Reports”American Academy of Pediatric Dentistry20:5 (1995) pp. 350-354.
C.P. Hill, et al. “The Structure of Granulocyte-Colony-Stimulating Factor and its Relationship to Other Growth Factor”PNASvol. 90 (Jun. 1993) pp. 5167-5171.
T. Zink, et al. “Structure and Dynamics of the Human Granulocyte Colony-Stimulating Factor Determined by NMR Spectroscopy, Loop Mobility in a Four-Helix-Bundle Protein”Biochemistry 33, (1994) pp. 8453-8463.
A.W. Burgess, et al. “Purification and Properties of Bacterially Synthesized Human Granulocyte-Macrophage Colony Stimulating Factor”Bloodvol. 69, No. 1 (Jan. 1987) pp. 43-51.
Knusli, C. et al., “Polyethylene glycol (PEG) modification of granulocyte-macrophage colony stimulating factor (GM-CSF) enhances neutrophil priming activity but not colony stimulating activity,”British Journal of Haematology, 82:654-663 (1992).
NCBI report for protein accession No. P04141.1, Jun. 10, 2008.
“Pharmacology: Drug delivery methods,” www.eyetee.net, Copyright 1997-2004, 3 pages.
Margolin et al., “Leakage Around Voice Prosthesis in Laryngectomees: Treatment with Local GM-CSF,”Head&Neck, 2001, 23:1006-1010.
Nashed et al., “Intraneural injection of corticosteroids to treat nerve damage in leprosy: a case report and review of literature,”J. Med. Case Reports, 2008, 2:381-385.
Wong et al., “Local vs systemic corticosteroids in the treatment of carpal tunnel syndrome,”Neurology, 2001, 56:1565-1567.
Zhang et al., “Local injection of insulin-zinc stimulates DNA synthesis in skin donor site wound,”Wound Rep. Reg., 2007, 15:258-265.
Greenstein, “Nonsurgical Periodontal Therapy in 2000: A Literature Review,”J. Am. Dent. Assoc., 2000, 131: 1580-1592.
Loesche, “The Antimicrobial Treatment of Periodontal Disease: Changing the Treatment Paradigm,”Crit. Rev. Oral Biol. Med., 1999, 10(3): 245-275.
Soskolne, “Subgingival Delivery of Therapeutic Agents in the Treatment of Periodontal Diseases,”Crit. Rev. Oral Biol. Med., 1997, 8(2): 164-174.
Wikipedia webpage, published Sep. 13, 2009, entitled “Route of Administration.”.
Chandra Gyan
Fish & Richardson P.C.
Innoventus Project AB
Landsman Robert
LandOfFree
Method of treating periodontal diseases by administering a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating periodontal diseases by administering a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating periodontal diseases by administering a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2649389